HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inflammatory Markers and Incidence of Hospitalization With Infection in Chronic Kidney Disease.

Abstract
Persons with chronic kidney disease (CKD) are at high risk of infection. While low-grade inflammation could impair immune response, it is unknown whether inflammatory markers are associated with infection risk in this clinical population. Using 2003-2013 data from the Chronic Renal Insufficiency Cohort Study (3,597 participants with CKD), we assessed the association of baseline plasma levels of 4 inflammatory markers (interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), interleukin-1 receptor antagonist (IL-1RA), and transforming growth factor-β (TGF-β)) with incident hospitalization with major infection (pneumonia, urinary tract infection, cellulitis and osteomyelitis, and bacteremia and sepsis). During follow-up (median 7.5 years), 36% (n = 1,290) had incident hospitalization with major infection. In multivariable Cox analyses with each inflammatory marker modeled as a restricted cubic spline, higher levels of IL-6 and TNF-α were monotonically associated with increased risk of hospitalization with major infection (for 95th vs. 5th percentile, hazard ratio = 2.11 (95% confidence interval: 1.68, 2.66) for IL-6 and 1.88 (95% confidence interval: 1.51, 2.33) for TNF-α), while corresponding associations for IL-1RA or TGF-β were nonsignificant. Thus, higher plasma levels of IL-6 and TNF-α, but not IL-1RA or TGF-β, were significantly associated with increased risk of hospitalization with major infection. Future studies should investigate whether inflammatory pathways that involve IL-6 and TNF-α increase susceptibility to infection among individuals with CKD.
AuthorsJunichi Ishigami, Jonathan Taliercio, Harold I Feldman, Anand Srivastava, Raymond Townsend, Debbie L Cohen, Edward Horwitz, Panduranga Rao, Jeanne Charleston, Jeffrey C Fink, Ana C Ricardo, James Sondheimer, Teresa K Chen, Myles Wolf, Tamara Isakova, Lawrence J Appel, Kunihiro Matsushita, CRIC Study Investigators
JournalAmerican journal of epidemiology (Am J Epidemiol) Vol. 189 Issue 5 Pg. 433-444 (05 05 2020) ISSN: 1476-6256 [Electronic] United States
PMID31673705 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Copyright© The Author(s) 2019. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: [email protected].
Chemical References
  • Biomarkers
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-6
  • Transforming Growth Factor beta
  • Tumor Necrosis Factor-alpha
Topics
  • Adult
  • Aged
  • Biomarkers (blood)
  • Disease Susceptibility
  • Female
  • Hospitalization (statistics & numerical data)
  • Humans
  • Incidence
  • Infections (immunology)
  • Inflammation (immunology)
  • Interleukin 1 Receptor Antagonist Protein (blood)
  • Interleukin-6 (blood)
  • Male
  • Middle Aged
  • Prospective Studies
  • Renal Insufficiency, Chronic (immunology)
  • Transforming Growth Factor beta (blood)
  • Tumor Necrosis Factor-alpha (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: